Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells
Molecular Medicine Reports · 03.03.2023 · 27 (4)
DOI: 10.3892/mmr.2023.12973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Medicine Reports, online erschienen am 03.03.2023. Verfasst von Tao Cai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai 20…. Hauptthemen laut MEDLINE: Bone Neoplasms, Exosomes, MicroRNAs, Osteosarcoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Osteosarcoma (OS) is the commonest primary malignant bone tumor in children and adolescents. However, chemotherapy resistance is a major challenge for the treatment of OS. Exosomes have been reported to serve an increasingly important role in different stages of tumor progression and chemotherapy resistance. The present study investigated whether exosomes derived from doxorubicin‑resistant OS cells (MG63/DXR) could be taken up in doxorubicin‑sensitive OS cells (MG63) and induce a doxorubicin‑resistant phenotype. MDR‑1, as the specific mRNA of chemoresistance, can be transferred by exosomes from MG63/DXR cells to MG63 cells. In addition, the present study identified 2,864 differentially expressed miRNAs (456 upregulated and 98 downregulated with fold‑change >2.0, P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, Shanghai Tenth People's Hospital Affiliated to Tongji University, Tongji University School of Medicine, Shanghai 200072, P.R. China.
Zitieren
APA
Cai, T., Zhang, C., & Zhan, T. (2023). Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells. Molecular Medicine Reports, 27(4). https://doi.org/10.3892/mmr.2023.12973
Vancouver
Cai T, Zhang C, Zhan T. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells. Molecular Medicine Reports. 2023;27(4). doi:10.3892/mmr.2023.12973
BibTeX
@article{Cai2023,
author = {Cai, Tao and Zhang, Chunlin and Zhan, Taichen},
title = {Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells},
journal = {Molecular Medicine Reports},
year = {2023},
volume = {27},
number = {4},
doi = {10.3892/mmr.2023.12973}
}
EUVIMED